{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:51:48Z","timestamp":1786992708131,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016806","name":"Natural Science Foundation of Nantong Municipality","doi-asserted-by":"publisher","award":["MS2023077"],"award-info":[{"award-number":["MS2023077"]}],"id":[{"id":"10.13039\/100016806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["Ym2023079"],"award-info":[{"award-number":["Ym2023079"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jiph.2025.103055","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:46:20Z","timestamp":1763538380000},"page":"103055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enhanced immune recovery with B\/F\/TAF compared with DTG\/3TC in HIV patients: A prospective observational study"],"prefix":"10.1016","volume":"19","author":[{"given":"Rui-Qi","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1204-592X","authenticated-orcid":false,"given":"Wen-Jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2025.103055_bib1","unstructured":"UNAIDS. Global HIV & AIDS statistics \u2014 Fact sheet, \u3008https:\/\/www.unaids.org\/en\/resources\/fact-sheet\u3009; 2025 [accessed 7 August 2025]."},{"key":"10.1016\/j.jiph.2025.103055_bib2","first-page":"225","article-title":"National HIV\/STD epidemic situation in China, December 2024","volume":"3","author":"National Center for AIDS\/STD Control and Prevention","year":"2025","journal-title":"Chin J AIDS STD"},{"issue":"1","key":"10.1016\/j.jiph.2025.103055_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11904-019-00478-x","article-title":"Optimizing treatment for adults with HIV\/AIDS in China: successes over two decades and remaining challenges","volume":"17","author":"Cao","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jiph.2025.103055_bib4","unstructured":"British HIV Association. BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022. Available from: \u3008https:\/\/www.bhiva.org\/file\/63513a1745ea9\/BHIVA-guidelines-on-antiretroviral-treatmentfor-adults-living-with-HIV-1-2022.pdf\u3009, 2022 [accessed 7 August 2025]."},{"key":"10.1016\/j.jiph.2025.103055_bib5","unstructured":"Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, \u3008https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv\u3009; 2025 [accessed 27 October 2025]."},{"key":"10.1016\/j.jiph.2025.103055_bib6","volume":"30","year":"2024","journal-title":"Chin J AIDS STD"},{"issue":"9","key":"10.1016\/j.jiph.2025.103055_bib7","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40262-020-00898-8","article-title":"Comparative clinical pharmacokinetics and pharmacodynamics of HIV-1 integrase strand transfer inhibitors: an updated review","volume":"59","author":"Podany","year":"2020","journal-title":"Clin Pharm"},{"issue":"10107","key":"10.1016\/j.jiph.2025.103055_bib8","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(17)32299-7","article-title":"Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial","volume":"390","author":"Gallant","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jiph.2025.103055_bib9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/ciac036","volume":"75","author":"Osiyemi","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jiph.2025.103055_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1902824","article-title":"Dolutegravir plus two different prodrugs of tenofovir to treat HIV","volume":"381","author":"Venter","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jiph.2025.103055_bib11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/hiv.13467","article-title":"Immune response to ART initiation in advanced HIV infection","volume":"24","author":"Mounzer","year":"2023","journal-title":"HIV Med"},{"issue":"6","key":"10.1016\/j.jiph.2025.103055_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/cid\/cix915","article-title":"Global Trends in CD4 cell count at the start of antiretroviral therapy: collaborative study of treatment programs","volume":"66","author":"IeDea","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.103055_bib13","first-page":"17","article-title":"Trend analysis of late presentation of patients with HIV\/AIDS with different characteristics in China between 2013 and 2023","volume":"31","author":"YANG Zhongnian","year":"2025","journal-title":"Chin J AIDS STD"},{"key":"10.1016\/j.jiph.2025.103055_bib14","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, 2nd ed, \u3008https:\/\/www.who.int\/publications\/i\/item\/9789241549684\u3009; 2016 [accessed 7 August 2025]."},{"issue":"8","key":"10.1016\/j.jiph.2025.103055_bib15","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/507313","article-title":"Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: an aids clinical trials group study","volume":"194","author":"Haas","year":"2006","journal-title":"J Infect Dis"},{"issue":"10107","key":"10.1016\/j.jiph.2025.103055_bib16","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(17)32340-1","volume":"390","author":"Sax","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jiph.2025.103055_bib17","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/S2352-3018(19)30077-3","article-title":"Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial","volume":"6","author":"Wohl","year":"2019","journal-title":"Lancet HIV"},{"issue":"22","key":"10.1016\/j.jiph.2025.103055_bib18","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1097\/CM9.0000000000002907","article-title":"Efficacy and safety profiles of dolutegravir plus lamivudine vs. bictegravir\/emtricitabine\/tenofovir alafenamide in therapy-naive adults with HIV-1","volume":"136","author":"Wei","year":"2023","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.jiph.2025.103055_bib19","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001949","article-title":"Safety and efficacy of lamivudine\/dolutegravir vs. bictegravir\/emtricitabine\/tenofovir alafenamide in antiretroviral-naive adults with HIV-1 infection in Shanghai, China: a single-centre retrospective study","volume":"74","author":"Yang","year":"2025","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103055_bib20","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1080\/21505594.2021.2004743","article-title":"Persistent low-Level viremia in persons living with HIV undertreatment: an unresolved status","volume":"12","author":"Crespo-Bermejo","year":"2021","journal-title":"Virulence"},{"issue":"9","key":"10.1016\/j.jiph.2025.103055_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa340","article-title":"Do Combination antiretroviral therapy regimens for HIV Infection Feature Diverse T-cell phenotypes and inflammatory profiles?","volume":"7","author":"Tincati","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiph.2025.103055_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.873408","article-title":"Similar CD4\/CD8 ratio recovery after initiation of dolutegravir plus lamivudine versus dolutegravir or bictegravir-based three-drug regimens in naive adults with HIV","volume":"13","author":"Martinez-Sanz","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103055_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12981-023-00507-1","article-title":"An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor-based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1","volume":"20","author":"Evitt","year":"2023","journal-title":"AIDS Res Ther"},{"issue":"17","key":"10.1016\/j.jiph.2025.103055_bib24","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s40265-018-1010-7","article-title":"Bictegravir\/emtricitabine\/tenofovir alafenamide: a review in HIV-1 infection","volume":"78","author":"Deeks","year":"2018","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.jiph.2025.103055_bib25","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/379667","article-title":"Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patients","volume":"188","author":"Rousseau","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2025.103055_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11904-022-00600-6","article-title":"Metabolic consequences of antiretroviral therapy","volume":"19","author":"Diggins","year":"2022","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"25 2","key":"10.1016\/j.jiph.2025.103055_bib27","first-page":"S1","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jiph.2025.103055_bib28","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jiph.2025.103055_bib29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/0956462416675107","article-title":"Integrase strand transfer inhibitor-associated diabetes mellitus: a case report","volume":"28","author":"Fong","year":"2017","journal-title":"Int J STD AIDS"},{"issue":"1","key":"10.1016\/j.jiph.2025.103055_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/jac\/dkx365","article-title":"Dolutegravir-induced hyperglycaemia in a patient living with HIV","volume":"73","author":"McLaughlin","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.jiph.2025.103055_bib31","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/S2352-3018(20)30042-4","article-title":"Dolutegravir-associated hyperglycaemia in patients with HIV","volume":"7","author":"Lamorde","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jiph.2025.103055_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae645","article-title":"Metabolic Complications After Initiating BIC\/FTC\/TAF Versus DTG + 3TC in ART-naive Adults With Human Immunodeficiency Virus (HIV): a multicenter prospective cohort study","author":"Garcia-Ruiz de Morales","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.103055_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/asheducation-2013.1.377","article-title":"Pathogenesis and clinical implications of HIV-related anemia in 2013","volume":"2013","author":"Redig","year":"2013","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.jiph.2025.103055_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106343","article-title":"HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance","volume":"57","author":"Mbhele","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"10.1016\/j.jiph.2025.103055_bib35","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/QAD.0000000000002223","article-title":"Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials","volume":"33","author":"Gupta","year":"2019","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.jiph.2025.103055_bib36","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/jac\/dkab481","article-title":"Real-life experience with bictegravir\/emtricitabine\/tenofovir alafenamide in a large reference clinical centre","volume":"77","author":"Ambrosioni","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jiph.2025.103055_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33054","article-title":"Liver function tests, CD4(+) counts, and viral load among people living with HIV on dolutegravir compared to efavirenz-based cART; a comparative cross-sectional study","volume":"10","author":"Mengistu","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jiph.2025.103055_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.ATV.0000148405.18071.6a","article-title":"Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction","volume":"25","author":"Kawamura","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.jiph.2025.103055_bib39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1468-1293.2012.01026.x","article-title":"Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV-infected adults on stable antiretroviral therapy","volume":"13","author":"Hileman","year":"2012","journal-title":"HIV Med"},{"key":"10.1016\/j.jiph.2025.103055_bib40","unstructured":"Administration NHS. Notice of the National Healthcare Security Administration and the Ministry of Human Resources and Social Security on Issuing the National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug List (2021), \u3008https:\/\/www.gov.cn\/zhengce\/zhengceku\/2021-12\/03\/content_5655651.htm\u3009; 2021 [accessed 7 August 2025]."}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125004046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125004046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:38:30Z","timestamp":1768811910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125004046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1876034125004046"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103055","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced immune recovery with B\/F\/TAF compared with DTG\/3TC in HIV patients: A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103055"}}